INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,739 | -14.7% | 256,887 | +14.5% | 0.01% | -14.3% |
| Q2 2023 | $2,038 | +31.7% | 224,405 | -6.3% | 0.01% | +16.7% |
| Q1 2023 | $1,547 | +8.6% | 239,448 | +6.6% | 0.01% | 0.0% |
| Q4 2022 | $1,424 | -99.9% | 224,579 | +14.9% | 0.01% | +20.0% |
| Q3 2022 | $1,212,000 | -29.9% | 195,486 | -7.5% | 0.01% | -37.5% |
| Q2 2022 | $1,729,000 | -21.2% | 211,318 | -18.9% | 0.01% | -11.1% |
| Q1 2022 | $2,195,000 | +88.9% | 260,710 | +128.9% | 0.01% | +80.0% |
| Q4 2021 | $1,162,000 | -39.8% | 113,914 | +14.7% | 0.01% | -37.5% |
| Q3 2021 | $1,929,000 | +91.6% | 99,323 | +73.2% | 0.01% | +100.0% |
| Q2 2021 | $1,007,000 | – | 57,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 178,284 | $1,219,463 | 0.13% |
| Fermata Advisors, LLC | 56,702 | $383,888 | 0.11% |
| Westside Investment Management, Inc. | 41,540 | $281,227 | 0.08% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $406,200 | 0.04% |
| MAI Capital Management | 97,410 | $659,466 | 0.01% |
| Janney Montgomery Scott LLC | 256,887 | $1,739 | 0.01% |
| Financial Advocates Investment Management | 11,510 | $78,320 | 0.01% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $7 | 0.00% |
| Beacon Pointe Advisors, LLC | 10,368 | $70,191 | 0.00% |
| Asset Dedication, LLC | 814 | $6 | 0.00% |